Abstract:
Markov chain controlled random modulation of switching signal sequences for a power converter. The control is implemented in a power converter having an energy storage device which receives an input power from a source and provides an output power to a load. The converter includes a switching device for coupling the input power source to the energy storage device or coupling the storage device to the load in response to receiving a sequence of control signals generated from a control signal generator. The control signal generator includes a switching signal generator for providing a nominal switching signal sequence which achieves steady state between the input power to the converter and the output power supplied to the load, a modulator for modulating the nominal switching signal sequence with a source of non-deterministic signals to produce a time modulated switching signal sequence, and a control device for controlling the modulator in response to determining the previous modifications performed to the nominal switching signal sequence to maintain a predetermined range of deviation between the time modulated switching signal sequence and the nominal switching signal sequence.
Abstract:
Particles are provided that are not rapidly cleared from the blood stream by the macrophages of the reticuloendothelial system, and that can be modified to achieve variable release rates or to target specific cells or organs. The particles have a biodegradable solid core containing a biologically active material and poly(alkylene glycol) moieties on the surface. The terminal hydroxyl group of the poly(alkylene glycol) can be used to covalently attach onto the surface of the particles biologically active molecules, including antibodies targeted to specific cells or organs, or molecules affecting the charge, lipophilicity or hydrophilicity of the particle. The surface of the particle can also be modified by attaching biodegradable polymers of the same structure as those forming the core of the particles. The typical size of the particles is between 1 nm and 1000 nm, preferably between 1 nm and 100 nm, although microparticles can also be formed as described herein. The particles can include magnetic particles or radiopaque materials, such as air and other gases, for diagnostic imaging, biologically active molecules to be delivered to a site, or compounds for targeting the particles. The particles have a prolonged half-life in the blood compared to particles not containing poly(alkylene glycol) moieties on the surface.
Abstract:
Pharmaceutical compositions for oral delivery are prepared by encapsulation of compounds to be delivered to the small intestine within polymerized liposomes. The constituent phospholipids and/or the leaflets are polymerized through double bond-containing olefinic and acetylenic phospholipids. Covalently binding the layers through polymerization adds strength, resulting in a less fluid unpolymerized liposome. Polymerized liposomes can also be prepared by chemical oxidation of thiol groups in the phospholipids to disulfide linkages. Biologically active substances, such as a drug or antigen, can be encapsulated during the polymerization by mixing the substances into the liposome components at the time the liposomes are formed. Alternatively, the liposomes can be polymerized first, and the biologically active substance can be added later by resuspending the polymerized liposomes in a solution of a biologically active substance, and sonicating the suspension or by drying the polymerized liposomes to form a film, and hydrating thefilm in a solution of the biologically active substance.
Abstract:
A method for incorporating future developments in video compression technology to migrate toward a better television system in a receiver-compatible manner. The invention uses enhancement data (34) that can be combined with standard video data (16). Standard HDTV receivers will utilize standard video data, ignoring the enhancement data. More advanced HDTV receivers (36) will combine the enhancement data with standard data. The television signal is transmitted in a format comprising a first set of bits (16) that represents images at a first quality (e.g., first resolution) and that can be decoded to provide an output (20) at the first resolution, and a second set of bits (34) that represents enhancement information and that can be decoded and used in conjunction with the first set of bits to provide an output (40) at a second resolution greater than the first resolution. The first set of bits (16) is decoded (18) according to a first decoding procedure to provide information (20) representative of images at the first resolution. The second set of bits (34) is decoded according to a second procedure (38) to provide the enhancement information. At least some of the enhancement information and at least some of the information representative of images at the first resolution are used to provide the output (40) at the second resolution.
Abstract:
A new technique has been developed to measure etching or deposition rate uniformity in situ using a CCD camera (342, 1742) which views the wafer (308, 1708) during plasma processing. The technique records the temporal modulation of plasma emission or laser illumination (360, 1770) reflected from the wafer (308, 1708); this modulation is caused by interferometry as thin films (313, 1713) are etched or deposited. The measured etching rates compare very well with those determined by Helium-Neon laser interference. This technique is capable of measuring etching rates across 100 mm or larger wafers (308, 1708). It can resolve etch rate variations across a wafer or within a die (308, 1708). The invention can also be used to make endpoint determinations in etching operations as well as measuring the absolute thickness of thin films (313, 1713).
Abstract:
There are first and second relatively movable plates (12 and 20). On a face of each of the first and second plates (12 and 20), there are first and second alignment marks (13 and 21), each being a linear grating of parallel lines of uniform spatial period, the spatial periods (P1 and P2) being different from each other. There is a light source for illuminating the linear grating on the second plate (20) through the linear grating on the first plate (12) to produce an interference pattern. Indicia on the first and second plates indicate a periodic reference pattern having a phase. A detector is configured to detect when the spatial phase of the interference pattern and the spatial phase of said reference pattern differ by a predetermined value. A position adjustor is for adjusting the relative position of the first and second plates until the detector detects said phase difference.
Abstract:
An electrochemical device (10) including a solid electrolyte (16) and a solid electrode (20) composed of materials having different chemical compositions and characterized by different electrical properties but having the same crystalline phase is provided. A method for fabricating an electrochemical device (10) having a solid electrode (20) and solid electrolyte (16) characterized by the same crystalline phase is also provided.
Abstract:
Quick and simple assays for apoptotic cell deaths and apoptotic and necrotic cell deaths are described, which are based on selective staining by the dyes toluidine blue, acridine orange, and Nile blue. Various tissue preparations, including live embryos and fixed tissue sections, can be assayed. Use of this assay to study cell deaths during Drosophila embryogenesis is described. Other uses of the assays, including environmental toxicity testing, identification of cell death-defective mutants, mapping of patterns of cell death in tissues, drug screening, and potential diagnostic and therapeutic uses, are also described. The present invention also relates to cell death genes, which are genes required for programmed cell deaths; mutant organisms, in which embryonic programmed cell death occurs to a less than normal extent; proteins encoded by the cell death genes; antibodies which bind the cell death gene products; and agents which alter the ability of cell death genes to cause programmed death of cells. As described herein, applicants have identified two genes which function in the initiation of apoptosis or programmed cell death. These two genes, referred to respectively as the reaper (rpr) gene and the head involution defective (hid) gene, map to position 75C1,2 on the third chromosome in Drosophila (D.) melanogaster and exibit expression patterns related to the pattern of cell death during Drosophila embryogenesis; mutations in each gene reduce levels of cell deaths or abolish cell death.
Abstract:
A single, reproducible scheme to simultaneously purify all three of the heparin lyases from F. heparinum to apparent homogeneity is disclosed herein. The kinetic properties of the heparin lyases have been determined as well as the conditions to optimize their activity and stability. Monoclonal antibodies to the three heparinases are also described and are useful for detection, isolation and characterization of the heparinases.
Abstract:
A method and apparatus for detecting cataractogenesis is disclosed. Quasielastic light scattering data are collected from the lens (12) of an individual to be tested for cataractogenesis. The data are collected from specific and reproducible sites within the lens by means of measurements made using a reticle (40) in the apparatus and processed by an autocorrelator (38). The data from the autocorrelator are then fit to a double exponential form of autocorrelation function and the resulting functional form is transformed to produce at least one dimensionless parameter Fmos. This parameter has been found to change predictably with the individual's age and, accordingly, is useful in detecting and determining the degree of cataractogenesis in the individual.